Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123274) titled 'Early Diagnosis and Risk Prediction of Alzheimer's Disease Based on Multimodal Neuroimaging and Blood Biomarkers' on April 23.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Affiliated Kangning Hospital of Ningbo University
Condition:
Alzheimers disease
Intervention:
Gold Standard:International Classification of Diseases and Related Health Problems
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: Target condition:100;Difficult condition:100
Countries of Recruitment:
China
To know more, visit https://www.c...